Revolution Medicines, Inc. ( RVMD) - Stock Earnings
RVMD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
RVMD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -364.9 million USD | — USD |
| 2026Q1 | -453.8 million USD | — USD |
| 2026Q2 | -644.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RVMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -436.4 million USD | 11.6 million USD |
| 2024 | -600.1 million USD | — USD |
| 2025 | -1.1 billion USD | — USD |
| 2026 Est. | — | — |
RVMD
Price: $189.76
52 week price:
Earnings Per Share: -8.87 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 856800
Market Capitalization: 43.9 billion